74471-68-4

Upstream product

• 100-52-7 benzaldehyde 
• 56-40-6 glycine 

Downstream Products

• 100-52-7 benzaldehyde 
• 139119-44-1 tert-Butyl (2RS)-5-Oxo-2-phenyloxazolidine-3-carboxylate 
• 139237-52-8 tert-Butyl (2R)-5-Oxo-2-phenyloxazolidine-3-carboxylate 
• 139237-51-7 tert-Butyl (2S)-5-Oxo-2-phenyloxazolidine-3-carboxylate 
• 7662-79-5 2-(N-benzylacetamido)acetic acid 
• 56-40-6 glycine 
• 193343-37-2 (C₆H₅)3Sn(C₆H₅CHNCH₂CO₂) 
• 94212-51-8 2-phenyl-3-(N,N-phthaloyl-glycyl)-oxazolidin-5-one 
• 139119-46-3 tert-Butyl (2R,4S)-4-Methyl-5-oxo-2-phenyloxazolidine-3-carboxylate 

Relevant academic research and scientific papers

Spectral studies and in vitro antimicrobial activity of new organotin(IV) complexes of Schiff bases derived from amino acids

Some new di- and triphenyltin(IV) complexes of the general formulae Ph2SnL and Ph3SnL', where H2L/HL' = Schiff bases derived from the condensation of 2-hydroxy-1-naphthaldehyde (H2L) and benzaldehyde (HL') with glycine (H2L-1/HL'-1), DL-α-alanine (H2L-2/HL'-2), L-methionine (H2L-3/HL'-3), DL-valine (H2L-4/HL-4), D-phenylalanine (H2L-5/HL'-5), 2-aminobutyric acid (H2L-6/HL'-6), and L-leucine (H2L-7/HL'-7), have been synthesized and characterized by elemental analyses, molar conductance, electronic, infrared and far-infrared, multinuclear magnetic resonance (1H, 13C, and 117Sn), and 119Sn Mossbauer studies. Thermal decomposition of a few complexes using TG, DTG, and DTA techniques indicates the formation of SnO2 as a residue. The complexes have also been tested in vitro against bacteria [Streptococcus faecalis, Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus Penicillin resistance (2500 units)] and fungi [Candida albicans, Cryptococcus neoformans, Sporotrichum schenckii, Trichophyton mentagrophytes, and Aspergillus fumigatus]. All of the complexes show remarkable activity.